VEGFB and neoplasm: Our data indicate that IDB0076 may also trigger cointernalization of a cognate receptor (VEGFR1 for VEGFB and PlGF2) by inducing cellular internalization of NRP1 and should break the resistance to bevacizumab by blocking these growth factors taking part in tumor angiogenesis.